Dermashine: Automated Microinjections and How They Differ

You have come across an offer for “Dermashine biorevitalisation” and wonder how it differs from ordinary hyaluronic-acid injections. The key distinction is that Dermashine names a family of automated microinjection devices, not one standard injectable substance. The machine controls the delivery of a substance through needles; what actually enters your skin depends on the selected product, its authorised purpose, injection depth and technique. So the question “Is Dermashine right for me?” has no meaningful answer until you ask “Exactly what will be injected, and why?”

Similar treatments may be called hydro-injections, skin boosters or device-assisted mesotherapy. These labels can conceal very different products and risks. The device alone does not guarantee hydration, replace basic care for dry skin or act like a volume-restoring filler. If you want to look rested with no visible marks over the coming days, the discussion about papules, bruises and ingredients is more important than the injector's speed.

What is Dermashine, and which model is being offered?

South Korean manufacturer Huons Meditech describes Dermashine PRO as an automatic injector that uses suction to bring the handpiece into contact with skin and offers multi-needle cartridges, including a nine-needle version. The PRO technical specification identifies model Panace-DS-51. Vacuum helps position the tip; a motor moves the syringe plunger to dispense a selected amount. That is a description of design and manufacturer-promoted advantages, not independent proof that every formulation hurts less or works better.

The range includes the original Dermashine, Dermashine PRO, Dermashine Balance and further devices, sometimes incorporating additional technologies. They should not be treated as one identical machine. Needle counts, syringe compatibility, injection controls, consumables and instructions can vary. If an offer says only “Dermashine”, ask for the exact model label, instruction manual, origin and packaging of the single-use cartridge.

On 22 August 2025, the manufacturer announced European MDR CE marking for Dermashine PRO and Balance. This is a statement from an interested company about named models, not our independent verification of their certificates or the status of every version worldwide. Before use, check the current certificate, declaration and permitted scope in the original documentation. This announcement proves neither Armenian registration nor local availability. Nor does the CE status of an injector establish US approval of a particular injectable product.

Why don't several needles guarantee a consistent outcome?

Automation can help repeat movements and dosing within the device's capabilities. Yet the state of the skin, facial area, contact angle, actual settings, anatomy and operator skill still influence injection depth and distribution. Suction contact may leave temporary small marks or tip impressions. The phrase “no manual injections” is misleading: needles still penetrate the skin barrier, with risks of bleeding, inflammation and infection.

A multi-needle cartridge may cover an area more quickly, but speed is not a clinical measure of quality. A faster session does not prove better results or eliminate the need for aseptic technique. Both the handpiece and injectable substance must be used in line with their respective instructions. Do not let product mixtures, volumes and injection depths be chosen solely because “this is what we always put into this machine”.

There is a significant professional caveat: a 2025 international consensus on mesotherapy generally advises against multi-injectors, emphasising careful technique and sterility. The consensus is not a trial of Dermashine PRO specifically, nor proof that every session with it is inevitably unsafe. It is nevertheless a reason not to regard multiple needles as an automatic advantage. Ask the doctor why automated delivery is chosen over individual manual injections and how that recommendation has been considered. The consensus explains why: with multiple needles it is harder to control each puncture depth independently, vary the spacing between injection sites or avoid moles and other skin lesions that should not be injected. This recommendation concerns mesotherapy technique in general; it is not a comparative trial of Dermashine PRO.

Four different questions concealed by the word “Dermashine”
Component	What it controls	What must be confirmed
Dermashine device and version	How microinjections are delivered and controlled	Exact model, instructions, maintenance
Cartridge, needles and consumables	Contact with skin and needle punctures	Sterile single-use supplies, compatibility, opening in front of you
Injected product	Possible biological effect and substance-specific risks	Name, ingredients, indication, packaging, expiry, authorised route
Medical professional and plan	Patient selection, depth, sites, asepsis, complication response	Clinical justification, qualifications, written consent and follow-up contact

Which skin changes can sensibly be discussed?

If a product specifically intended for superficial injection is used, any effect depends on its ingredients and clinical evidence, not the injector brand. Some hyaluronic-acid formulations are studied or offered for hydration, smoothness or fine lines; evidence for other mixtures may be of very different quality. Even if products are both marketed as “skin boosters”, their formulations, concentrations and indications are not interchangeable.

An effect does not necessarily appear immediately. In the early days skin can look fuller because of swelling and superficial papules—small raised bumps at injection sites. This is not proof of improved skin structure. Duration of effect, number of sessions and repeat treatment depend on the substance and your skin, so a universal “three-session course” cannot be inferred from the word Dermashine.

For very dry skin, first distinguish dehydration from irritation caused by skin care, atopic dermatitis and age-related changes. If products sting, skin flakes or feels tight, restoring the barrier or treating a dermatological condition may matter more than injections. Superficial mesotherapy will not provide the lifting or volume replacement expected for significant laxity or a deep fold. Sometimes a simpler, non-injectable routine with careful observation serves your goal better.

If you do want an injectable skin booster, compare the specific products that are legally authorised in the relevant market and their instructions, not just delivery devices. Separate guides on skin boosters and biorevitalisation and skin booster injections explain formulas and the wider category. The decision on this page is what the automated injector does—or does not—add.

What happens in the clinic, and how uncomfortable is it?

First comes a medical history: allergies, previous injections or fillers, reactions to anaesthetics, skin disease, herpes, clotting disorders, medication, pregnancy or breastfeeding. A clinician examines the skin and explains what the chosen product might reasonably achieve. If the formula is still unknown, it is too early to sign consent. You need to understand what is being placed into the tissue, not just the Dermashine label.

The area should be cleaned and disinfected, sterile supplies prepared, and the syringe and tip checked for compatibility. Topical anaesthesia may be considered depending on the plan, but cannot guarantee total comfort. Suction can feel like momentary pulling; needles may feel like repeated brief stings or pressure. Thin skin and bony areas may feel different from the cheeks. The operator must stop if sharp unusual pain, skin colour change or another unexpected reaction appears.

Small raised injection marks, red dots, swelling, bruises and tenderness are possible afterwards. They may barely matter on a video call from home but be very noticeable in close-up photographs. There is no reliable universal deadline for disappearance: it depends on the number of punctures, product, blood-vessel response, medications and individual healing. Bruising is especially easy to underestimate when booking a first session just before a celebration.

Planning for visible marks after microinjections
Stage	What might show	What to plan
Immediately afterwards	Red dots, suction-tip impressions, papules and swelling	Do not treat the immediate appearance as the final result
Over the next days	Swelling gradually settles; a bruise may only appear later	Leave spare time before essential close-up photographs
Once marks have settled	Skin can be judged without early swelling	Compare baseline photos taken in similar light
If symptoms worsen	Spreading redness, heat, pus, severe pain or unusual blanching	Seek prompt medical review instead of another cosmetic session

Protect puncture sites against dirt, friction and irritating products. Ask the treating clinician when makeup, workouts, sauna and active skin care may be resumed for the substance used. Do not conceal strongly irritated skin under heavy foundation. Request written aftercare and a direct contact for questions before leaving the clinic.

Which risks come from the device, and which from the injection?

There are three layers. First, the needle itself can cause pain, pinpoint bleeding and irritation. Second, lapses in sterility can produce bacterial infection and other complications: sterile disposable cartridges, skin antisepsis and a suitable treatment environment matter more than attractive packaging. Third, the injected substance may cause allergy, inflammation, nodules, unexpected effects or be inappropriate for a particular site. A painless injection is not proof that the product is safe.

Fillers and some volume-building injectables have an additional hazard: material can enter a blood vessel and compromise tissue perfusion. The FDA describes rare but serious consequences, including tissue necrosis and visual injury. It would be wrong to transfer the same frequencies and risk profile automatically to every superficial Dermashine preparation. It would also be wrong to promise that all facial injections are free of vascular complications. Risk depends on the substance, depth, area and technique. Ask the medical practitioner for a clear advance plan for suspected vascular compromise, allergy or infection.

Extra caution is needed with active herpes, pustular eruptions, broken skin, significant allergies, bleeding disorders or anticoagulants, earlier fillers in the same area and diseases affecting healing. These are not identical absolute prohibitions for all patients; a clinician must examine the particular concern and the product's instructions. Elective cosmetic injections are best deferred in pregnancy. During breastfeeding, the substance and need for the procedure require individual medical consideration as well.

Unusual escalating pain, sudden pale or mottled skin, impaired vision or signs of a serious allergic reaction require immediate medical evaluation. Fever, spreading redness, increasing swelling or discharge from punctures call for urgent examination for possible infection. Do not try to massage an affected area or administer any “antidote” yourself at home.

When might manual injections or non-invasive care be wiser?

For a small area or complex anatomy, a qualified professional may favour individual manual injections to control each placement and avoid a multi-needle pattern. Manual technique is not automatically safe either: expertise and sterile practice still matter. There should be a clinical reason for the instrument choice, especially given the international mesotherapy consensus's caution about multi-injectors.

If skin is dehydrated from strong acids or over-washing, first consider mild cleansing, a barrier-supporting moisturiser and sun protection. Rosacea, eczema or inflammatory acne call for diagnosis and condition-specific care first. Filling a deep nasolabial fold is a different objective with different products, risks and planning. And if you are happy with your current skin, not having injections is a complete, valid decision, not a missed opportunity.

What documents and information should you request?

The full Dermashine model name and manual; documentation for the device and disposable supplies, including compatibility.
Trade name and manufacturer of the injected product, ingredients, batch number, expiry, legal status and authorised route of administration in the relevant market.
A reason for selecting automated multi-needle injection over a manual approach in light of mesotherapy recommendations; proposed areas and what happens if pain occurs.
The practitioner's medical qualifications, aseptic conditions, content of informed consent and response plan for complications.
A realistic account of visible marks, when to postpone for inflammation, the full cost breakdown and written aftercare contact details.

Do not agree to a nameless “universal cocktail” without its package and instructions, a reused cartridge, or treatment where staff refuse to identify the injected substance. In Yerevan and elsewhere in Armenia, certification under a foreign regulatory system does not itself establish lawful local registration or use of the exact model and injectable product; these must be checked separately. Being free to decline after a consultation matters more than a promise of a “five-minute procedure”.

Further questions

Can I bring an ampoule I purchased myself?

Do not hand over an unverified or self-purchased injectable solution. Authenticity, sterility, storage conditions, the authorised route and device compatibility must all be checked. A medical professional should assess and prepare the product.

What if I already have facial fillers?

Tell the clinician which filler was used, where and when. Existing material may alter the site or injection-depth plan, and some situations call for avoiding mesotherapy. The decision depends on the exact filler and examination.

Can I have a facial massage immediately afterwards?

Do not rub or heat freshly punctured skin on your own initiative. The right interval before massage or device-based skin care depends on the product, visible reaction and the doctor's written instructions.

May I keep a record of the packaging and treatment?

Yes. Request documentation of the exact product name, batch, expiry, volume, injection areas and practitioner. It is especially useful if another clinician later has to evaluate an adverse reaction.